EXHIBIT 23.1

            CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the reference to our firm under the caption "Experts" and to the
use of our report dated March 10, 2006 in Amendment No. 3 to the Registration
Statement (Form S-1 No. 333-134311) and related prospectus of ImaRx
Therapeutics, Inc. for the registration of shares of its common stock.


                                                        /s/ Ernst & Young LLP
Phoenix, Arizona
August 30, 2006